About Mendea Technologies

Mendea is developing a wearable, non-invasive ultrasound brain stimulation device designed for clinical and therapeutic applications, as well as cognitive enhancement. The technology aims to improve outcomes for neurological disorders such as depression and addiction by providing customized brain stimulation to enhance mental well-being and cognitive performance.

```xml <problem> Current brain stimulation techniques often require invasive procedures or lack precise targeting, limiting their applicability for widespread clinical and therapeutic use. Existing non-invasive methods may also suffer from limited efficacy or inconsistent results due to challenges in delivering focused stimulation to specific brain regions. </problem> <solution> Mendea is developing a wearable, non-invasive neuromodulation device that utilizes low-intensity focused ultrasound (LIFU) to stimulate specific brain regions. This technology aims to provide a safe and customizable approach to brain stimulation for various applications, including clinical treatments, therapeutic interventions, and cognitive enhancement. The device incorporates one or more ultrasound transducers into a wearable headset, allowing for targeted neuromodulation. By leveraging LIFU, Mendea seeks to overcome the limitations of existing brain stimulation techniques, offering a versatile platform for improving brain function and addressing neurological disorders. </solution> <features> - Wearable headset design for comfortable and convenient non-invasive brain stimulation - Low-intensity focused ultrasound (LIFU) technology for targeted neuromodulation - Customizable stimulation parameters to tailor treatment for individual needs - Potential applications in depression, addiction, essential tremor, memory enhancement, and pain management - Integration with EEG devices for real-time monitoring of brain activity - Compatibility with closed-loop brain stimulation protocols </features> <target_audience> The primary target audience includes clinicians treating neurological disorders, therapists seeking innovative interventions, and individuals interested in cognitive enhancement and mental well-being. </target_audience> ```

What does Mendea Technologies do?

Where is Mendea Technologies located?

Mendea Technologies is based in London, United Kingdom.

When was Mendea Technologies founded?

Mendea Technologies was founded in 2024.

Location

London, United Kingdom

Founded

2024

Employees

1 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Mendea Technologies

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

mendea.co.uk 100+

Founded 2024 – London, United Kingdom

Funding

No funding information available.

Team (<5)

No team information available.

Company Description

Problem

Current brain stimulation techniques often require invasive procedures or lack precise targeting, limiting their applicability for widespread clinical and therapeutic use. Existing non-invasive methods may also suffer from limited efficacy or inconsistent results due to challenges in delivering focused stimulation to specific brain regions.

Solution

Mendea is developing a wearable, non-invasive neuromodulation device that utilizes low-intensity focused ultrasound (LIFU) to stimulate specific brain regions. This technology aims to provide a safe and customizable approach to brain stimulation for various applications, including clinical treatments, therapeutic interventions, and cognitive enhancement. The device incorporates one or more ultrasound transducers into a wearable headset, allowing for targeted neuromodulation. By leveraging LIFU, Mendea seeks to overcome the limitations of existing brain stimulation techniques, offering a versatile platform for improving brain function and addressing neurological disorders.

Features

Wearable headset design for comfortable and convenient non-invasive brain stimulation

Low-intensity focused ultrasound (LIFU) technology for targeted neuromodulation

Customizable stimulation parameters to tailor treatment for individual needs

Potential applications in depression, addiction, essential tremor, memory enhancement, and pain management

Integration with EEG devices for real-time monitoring of brain activity

Compatibility with closed-loop brain stimulation protocols

Target Audience

The primary target audience includes clinicians treating neurological disorders, therapists seeking innovative interventions, and individuals interested in cognitive enhancement and mental well-being.